0001562180-19-004122.txt : 20190801
0001562180-19-004122.hdr.sgml : 20190801
20190801161401
ACCESSION NUMBER: 0001562180-19-004122
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190801
FILED AS OF DATE: 20190801
DATE AS OF CHANGE: 20190801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COOKE MICHAEL P.
CENTRAL INDEX KEY: 0001741288
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38541
FILM NUMBER: 19992837
MAIL ADDRESS:
STREET 1: C/O MAGENTA THERAPEUTICS
STREET 2: 50 HAMPSHIRE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Magenta Therapeutics, Inc.
CENTRAL INDEX KEY: 0001690585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-201-2700
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-08-01
false
0001690585
Magenta Therapeutics, Inc.
MGTA
0001741288
COOKE MICHAEL P.
C/O MAGENTA THERAPEUTICS, INC.
100 TECHNOLOGY SQUARE, 5TH FLOOR
CAMBRIDGE
MA
02139
false
true
false
false
Chief Scientific Officer
common stock
2019-08-01
4
S
false
5000.00
13.4217
D
273023.00
D
common stock
2019-08-01
4
S
false
2500.00
13.409
D
270523.00
D
This trade is pursuant to an active 10b5-1 plan.
This transaction was executed in multiple trades at prices ranging from $13.40 to $13.4325. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request by the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
/s/ Zoran Zdraveski, Attorney-in-Fact for Michael P. Cooke
2019-08-01